Stock 2511 HIGHTIDE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases HighTide Therapeutics, Inc.

Equities

2511

KYG4568L1023

Market Closed - Hong Kong S.E.
Other stock markets
 09:08:57 25/06/2024 BST 		5-day change 1st Jan Change
1.63 HKD +7.24% Intraday chart for HighTide Therapeutics, Inc. -55.71% -87.42%
06-21 217,225,044 Shares of HighTide Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 21-JUN-2024. CI
06-18 8,774,232 Shares of HighTide Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 18-JUN-2024. CI

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
HighTide Therapeutics Presents Analyses of a Phase 2 T2DM Study
AQ
HighTide Therapeutics Presents Analyses of a Phase 2 T2DM Study at the ADA Scientific Sessions, Highlighting Glycemic and Cardiometabolic Benefits of Berberine Ursodeoxycholate (HTD1801)
AQ
HighTide Therapeutics Presents Analyses of Phase 2a MASH Study at the 2024 International Liver Congress, Reinforcing and Further Characterizing the Efficacy and Safety of Berberine Ursodeoxcyholate...
EQ
HighTide Therapeutics Presents Analyses of Phase 2a MASH Study
AQ
HighTide Therapeutics Presents Analyses of Phase 2a MASH Study at the 2024 International Liver Congress, Reinforcing and Further Characterizing the Efficacy and Safety of Berberine Ursodeoxcyholate (HTD1801)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 2511 Stock
  4. News HighTide Therapeutics, Inc.
  5. Press Releases